Breaking News Instant updates and real-time market news.

COLL

Collegium Pharmaceutical

$21.43

0.08 (0.37%)

08:45
02/07/18
02/07
08:45
02/07/18
08:45

Collegium Pharmaceutical price target raised to $35 from $28 at Needham

Needham analyst Serge Belanger raised his price target on Collegium Pharmaceutical to $35, citing a strong start to 2018 marked by the closing of the Nucynta licensing agreement and Xtampza Rx growth. Belanger says Nucynta is now being commercialized by the company and is expected to generate FY18 sales of $236M, while Xtampza's inclusion as the exclusive oxycodone ER on numerous prominent payor formularies should raise its FY18 sales to about $75M from prior view of $60M. Belanger keeps his Buy rating on Collegium Pharmaceutical.

  • 08

    Feb

  • 28

    Feb

  • 01

    Mar

COLL Collegium Pharmaceutical
$21.43

0.08 (0.37%)

12/05/17
12/05/17
UPGRADE
Target $9

Buy
Depomed upgraded to Buy after opiod exit deal at Mizuho
As previously reported, Mizuho analyst Irina Koffler upgraded Depomed (DEPO) to Buy from Neutral after the company agreed to license rights to commercialize the Nucynta franchise to Collegium (COLL). With the deal, Depomed exits the opioid space and significantly lowers its operating expenses, said Koffler, who raised her price target on Depomed shares to $9 from $6.
12/07/17
PIPR
12/07/17
NO CHANGE
Target $24
PIPR
Overweight
Piper survey suggests continued strong growth for Collegium's Xtampza
Piper Jaffray analyst David Amsellem says his firm's "brief survey" of 25 pain specialists who write a significant number of prescriptions for extended-release opioids indicates that a "solid majority" of physicians view Collegium Pharmaceutical's Xtampza ER as having less in the way of tampering/abuse potential compared to OxyContin. The analyst sees "high visibility" into Xtampza's continued strong volume growth for 2018 and beyond. He reiterates an Overweight rating on Collegium shares with a $24 price target.
01/23/18
PIPR
01/23/18
NO CHANGE
Target $33
PIPR
Overweight
Collegium Pharmaceutical price target raised to $33 from $23 at Piper Jaffray
Piper Jaffray analyst David Amsellem raised his price target for Collegium Pharmaceutical to $33 after speaking with senior management. The analyst continues to believe that visibility into continued aggressive volume growth for Xtampza ER is high given what its better tamper/abuse risk profile compared to OxyContin. Peak Xtampza ER sales of at least $400M-$500M are realistic, Amsellem tells investors in a research note. He reiterates an Overweight rating on Collegium shares.
02/06/18
JANY
02/06/18
NO CHANGE
Target $26
JANY
Buy
Collegium price target raised to $26 from $21 at Janney Capital
Janney Capital analyst Ken Trbovich raised his Q4 and 2018 estimates for Collegium Pharmaceutical based on strong Xtampza prescribing trends, which he contends "provide ample evidence" of the improved coverage for the drug. The analyst, who also updated his model to include the impact of the agreement for marketing rights for Nucynta and Nucynta ER, raised his fair value estimate on Collegium shares to $26 from $21 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

VIPS

Vipshop

$11.65

0.425 (3.79%)

15:25
06/18/18
06/18
15:25
06/18/18
15:25
Options
Vipshop call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

TFX

Teleflex

$280.29

-1.61 (-0.57%)

15:20
06/18/18
06/18
15:20
06/18/18
15:20
Conference/Events
Teleflex management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 21

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

  • 05

    Sep

GME

GameStop

$14.27

0.355 (2.55%)

15:19
06/18/18
06/18
15:19
06/18/18
15:19
Periodicals
GameStop talks with PE firms after seeing takeover interest, Reuters says »

GameStop is holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

OFC

Corporate Office Properties

$27.36

-0.055 (-0.20%)

15:18
06/18/18
06/18
15:18
06/18/18
15:18
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/18/18
06/18
15:17
06/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/18/18
06/18
15:16
06/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$14.27

0.355 (2.55%)

15:11
06/18/18
06/18
15:11
06/18/18
15:11
Hot Stocks
Breaking Hot Stocks news story on GameStop 

GameStop trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

HDP

Hortonworks

$19.96

0.86 (4.50%)

15:10
06/18/18
06/18
15:10
06/18/18
15:10
Options
Higher call activity in HortonNetworks as shares see relative strength »

Higher call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:10
06/18/18
06/18
15:10
06/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

GME

GameStop

$14.29

0.375 (2.69%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Hot Stocks
GameStop jumps after Reuters reports on takeover interest »

Shares of GameStop (GME)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

QTNT

Quotient

$8.33

1.2 (16.83%)

15:08
06/18/18
06/18
15:08
06/18/18
15:08
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GME

GameStop

$14.30

0.385 (2.77%)

15:06
06/18/18
06/18
15:06
06/18/18
15:06
Periodicals
Breaking Periodicals news story on GameStop »

GameStop talks with PE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

GME

GameStop

$14.31

0.395 (2.84%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Hot Stocks
Breaking Hot Stocks news story on GameStop »

GameStop trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 28

    Jun

SKX

Skechers

$29.23

-0.2 (-0.68%)

15:05
06/18/18
06/18
15:05
06/18/18
15:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CME

CME Group

$169.09

-0.7 (-0.41%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Conference/Events
CME Group management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 26

    Jul

BIG

Big Lots

$41.35

0.11 (0.27%)

14:55
06/18/18
06/18
14:55
06/18/18
14:55
Options
Big Lots put volume heavy and directionally bearish »

Bearish flow noted in Big…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

, CTWS

Connecticut Water

$65.50

0.5 (0.77%)

14:49
06/18/18
06/18
14:49
06/18/18
14:49
Hot Stocks
SJW sees giving shareholders chance to vote on Connecticut Water deal ASAP »

SJW Group (SJW) commented…

SJW

SJW Corp.

$66.69

-0.16 (-0.24%)

CTWS

Connecticut Water

$65.50

0.5 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$98.07

3.2 (3.37%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Recommendations
PTC analyst commentary  »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

OXY

Occidental Petroleum

$84.23

0.9 (1.08%)

14:45
06/18/18
06/18
14:45
06/18/18
14:45
Options
Occidental Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$43.86

1.33 (3.13%)

14:41
06/18/18
06/18
14:41
06/18/18
14:41
Recommendations
Etsy analyst commentary  »

Etsy price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

BUD

AB InBev

$96.45

-2.05 (-2.08%)

14:37
06/18/18
06/18
14:37
06/18/18
14:37
Hot Stocks
AB InBev, Kiip launch blockchain mobile ad campaign »

Kiip and AB Inbev…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

GSKY

GreenSky

$24.15

-0.12 (-0.49%)

14:36
06/18/18
06/18
14:36
06/18/18
14:36
Initiation
GreenSky initiated  »

GreenSky initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXC

DXC Technology

$83.05

-0.805 (-0.96%)

14:34
06/18/18
06/18
14:34
06/18/18
14:34
Hot Stocks
SOLUTIONS 30, DXC sign strategic partnership in Italy »

SOLUTIONS 30 Italia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$9.50

0.01 (0.11%)

14:25
06/18/18
06/18
14:25
06/18/18
14:25
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
06/18/18
06/18
14:25
06/18/18
14:25
General news
More from Bostic: a possible yield curve inversion »

More from Bostic: a…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.